These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 30307407)

  • 1. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
    Wei J; Marisetty A; Schrand B; Gabrusiewicz K; Hashimoto Y; Ott M; Grami Z; Kong LY; Ling X; Caruso H; Zhou S; Wang YA; Fuller GN; Huse J; Gilboa E; Kang N; Huang X; Verhaak R; Li S; Heimberger AB
    J Clin Invest; 2019 Jan; 129(1):137-149. PubMed ID: 30307407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.
    Atai NA; Bansal M; Lo C; Bosman J; Tigchelaar W; Bosch KS; Jonker A; De Witt Hamer PC; Troost D; McCulloch CA; Everts V; Van Noorden CJ; Sodek J
    Immunology; 2011 Jan; 132(1):39-48. PubMed ID: 20722758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
    Xu S; Wei J; Wang F; Kong LY; Ling XY; Nduom E; Gabrusiewicz K; Doucette T; Yang Y; Yaghi NK; Fajt V; Levine JM; Qiao W; Li XG; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24974128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
    Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
    Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
    Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB
    Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers.
    Woroniecka KI; Rhodin KE; Dechant C; Cui X; Chongsathidkiet P; Wilkinson D; Waibl-Polania J; Sanchez-Perez L; Fecci PE
    Clin Cancer Res; 2020 Mar; 26(6):1349-1358. PubMed ID: 31871298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.
    Henry A; Nokin MJ; Leroi N; Lallemand F; Lambert J; Goffart N; Roncarati P; Bianchi E; Peixoto P; Blomme A; Turtoi A; Peulen O; Habraken Y; Scholtes F; Martinive P; Delvenne P; Rogister B; Castronovo V; Bellahcène A
    Oncotarget; 2016 Sep; 7(39):63708-63721. PubMed ID: 27563812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
    Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
    Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion.
    Chen Q; Jin J; Huang X; Wu F; Huang H; Zhan R
    J Exp Clin Cancer Res; 2021 May; 40(1):160. PubMed ID: 33964937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.
    Klement JD; Paschall AV; Redd PS; Ibrahim ML; Lu C; Yang D; Celis E; Abrams SI; Ozato K; Liu K
    J Clin Invest; 2018 Dec; 128(12):5549-5560. PubMed ID: 30395540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
    Eder K; Kalman B
    Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
    Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
    Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
    Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.
    Chen P; Zhao D; Li J; Liang X; Li J; Chang A; Henry VK; Lan Z; Spring DJ; Rao G; Wang YA; DePinho RA
    Cancer Cell; 2019 Jun; 35(6):868-884.e6. PubMed ID: 31185211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma.
    Hutter G; Theruvath J; Graef CM; Zhang M; Schoen MK; Manz EM; Bennett ML; Olson A; Azad TD; Sinha R; Chan C; Assad Kahn S; Gholamin S; Wilson C; Grant G; He J; Weissman IL; Mitra SS; Cheshier SH
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):997-1006. PubMed ID: 30602457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
    Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
    Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.